<DOC>
	<DOCNO>NCT00724958</DOCNO>
	<brief_summary>The current observational program determine collect data real life dose regimen Remicade patient Crohn 's disease ( CD ) hospital non-hospital setting .</brief_summary>
	<brief_title>Program Extension Real Life Dosing Remicade Austria Crohn 's Disease ( Study P04052 ) ( COMPLETED )</brief_title>
	<detailed_description>This study population choose non-probability sample</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Subjects active luminal and/or fistulizing CD . Per summary product characteristic .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>